BSE filing, NSE: LIBERTSHOE. Summary written from the filing by ALFA Finder's alert engine.
Liberty Shoes Ltd: key numbers
- Share price
- ₹192.90
- Market cap
- ₹328.7 Cr
- Revenue (annual)
- ₹740.0 Cr
- Net profit (annual)
- ₹11.19 Cr
- P/E (TTM)
- 38.5×Sector 61.8×
- Promoter holding
- 59.83%+0.50% QoQ
- FII holding
- 0.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Liberty Shoes Ltd
All →Liberty Shoes Board Meeting Date
Liberty Shoes has scheduled a board meeting for November 12, 2026. The meeting will consider unaudited results for the quarter and half year ended September 30, 2026.
Liberty Shoes Other Announcement
Liberty Shoes Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 30, 2026. This is a standard periodic regulatory disclosure.
Liberty Shoes Legal & Regulatory
Liberty Shoes received a SEBI clarification regarding its pending promoter reclassification requests and the associated administrative warning letter dated July 21, 2026.
Liberty Shoes Management Change
Liberty Shoes re-appointed Piyush Dixit and Anand Das Mundhra as Independent Directors and appointed Raman Bansal as Executive Director, as approved at the 40th AGM.
Liberty Shoes Annual General Meeting
Liberty Shoes Ltd held its 40th Annual General Meeting on September 29, 2026, through video conferencing to discuss company operations and proposed resolutions.
Liberty Shoes Other Announcement
Liberty Shoes informed exchanges about dispatching letters to shareholders, providing the web-link for the 40th Annual General Meeting notice and the FY 2025-26 Annual Report.
Other board meeting date announcements
All →Vaishali Pharma Board Meeting Date
Vaishali Pharma has scheduled an audit committee meeting for 5 November 2026. Proposed agenda includes a fund raise via preferential issue and an increase in authorised capital.
Ventura Textiles Board Meeting Date
Ventura Textiles scheduled a board meeting for 9 November 2026 to consider unaudited results and new business strategy. The agenda is proposed until the meeting is held.
Sampre Nutritions Board Meeting Date
Sampre Nutritions has scheduled a board meeting on 6 November 2026 to consider its unaudited Q2 FY27 standalone and consolidated results. The filing is an advance notice with no results figures yet disclosed.
National General Industries Board Meeting Date
National General Industries will hold a board meeting on November 10, 2026 to consider unaudited quarterly results. Trading window stays closed until November 16, 2026.
Vision Cinemas Board Meeting Date
Vision Cinemas Limited has intimated a board meeting on 10 November 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. The trading window is closed from 1 October 2026 until 48 hours after results declaration.
Gujarat Narmada Valley Fertilizers & Chemicals Board Meeting Date
GNFC clarified its November 2, 2026 board meeting date was wrongly printed as 2025 in earlier intimations. Only the date is corrected; other information is unchanged.